Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

6.53USD
21 Sep 2018
Change (% chg)

$-0.40 (-5.77%)
Prev Close
$6.93
Open
$6.60
Day's High
$6.65
Day's Low
$6.22
Volume
310,936
Avg. Vol
172,766
52-wk High
$9.49
52-wk Low
$1.29

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Richard Uihlein

72 2018 Chairman of the Board

Harold Shlevin

68 2018 President, Chief Executive Officer, Chief Operating Officer

Jack Callicutt

51 2018 Chief Financial Officer, Company Secretary

Eliezer Zomer

71 2000 Executive Vice President - Manufacturing and Product Development

J. Rex Horton

48 2013 Executive Director - Regulatory Affairs and Quality Assurance